Skip to content

Clinical trials

Terminated Ovarian Neoplasms trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Status: Terminated Country / region: Germany Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20093
20112
20121
20142
20163
20182
20192
20211
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated19

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
Amgen2
AGO Research GmbH1
Dr. Horst Schmidt Klinik GmbH1
Genzyme, a Sanofi Company1
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH1
Mario Negri Institute for Pharmacological Research1
Menarini Group1
Morphotek1
Mural Oncology, Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms19
Fallopian Tube Neoplasms5
Recurrence3
Breast Neoplasms2
Carcinoma, Non-Small-Cell Lung2
Carcinoma, Ovarian Epithelial2
Melanoma2
Anemia1
Carcinoma, Adenoid Cystic1
Cholangiocarcinoma1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.